Ubs Asset Management Americas Inc Axogen, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 54,945 shares of AXGN stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,945
Previous 112,381
51.11%
Holding current value
$1.3 Million
Previous $1.22 Million
19.61%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AXGN
# of Institutions
185Shares Held
41.6MCall Options Held
86.4KPut Options Held
14.3K-
First Light Asset Management, LLC Edina, MN5.81MShares$137 Million12.43% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$76.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$63.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.43MShares$57.5 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.96MShares$46.3 Million0.75% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $1B
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...